Google says health projects will continue even as it unwinds dedicated health division
Fierce Healthcare
AUGUST 20, 2021
Google says health projects will continue even as it unwinds dedicated health division. hlandi. Fri, 08/20/2021 - 19:08.
Fierce Healthcare
AUGUST 20, 2021
Google says health projects will continue even as it unwinds dedicated health division. hlandi. Fri, 08/20/2021 - 19:08.
pharmaphorum
AUGUST 16, 2021
UK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed second-round financing that will help fund clinical development of its psilocybin-based therapies. The Oxford-based company had originally hoped to raise $50 million from the series B, and the scale of the financing is further evidence that repurposing psychedelic compounds as potential therapies for neuro-psychiatric disorders is a hot topic in biopharma.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
AUGUST 16, 2021
The check-in with nearly 1,800 US healthcare consumers reflects how COVID-19 and other factors have impacted patient access, equity, experience and trust.
Pharma Marketing Network
AUGUST 18, 2021
SAVE THE DATE – PMN Fall 2021 Summit: Pharma-Marketing Innovations & Trends of 2021 | SEP. 16th, 12:00PM – 1:30PM EST. SAVE YOUR SEAT TODAY. Telehealth: Is It Here to Stay? Once considered a novelty, over the past 18 months, Telehealth has risen to a prominent position in the continuum of care. Pharmaceutical brands must adapt to this new modality and pivot their promotional efforts to ensure that they can leverage the Telehealth channel effectively.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
AUGUST 19, 2021
Insurers take cue from providers, begin requiring vaccines for employees. pminemyer. Thu, 08/19/2021 - 12:32.
pharmaphorum
AUGUST 19, 2021
Novartis’ Rydapt has become the first and only licensed treatment for rare and life-threatening blood disorder systemic mastocytosis (SM) to be cleared for routine NHS use, after getting a green light from NICE. The decision means around 170 people with advanced SM in England and Wales will be eligible for treatment with oral, twice-daily drug, which since 2018 has also been cleared for NHS treatment of a form of acute myeloid leukaemia.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Times
AUGUST 19, 2021
Public consultation launches on proposed changes aiming to provide earlier access to new treatments
Fierce Healthcare
AUGUST 19, 2021
Cerner taps Google, Geisinger vet David Feinberg as new CEO. hlandi. Thu, 08/19/2021 - 21:17.
pharmaphorum
AUGUST 17, 2021
Rapid advances in the use of artificial intelligence (AI) in healthcare and medicines development are at risk of outstripping current regulatory frameworks, according to a new report. The International Coalition of Medicines Regulatory Authorities (ICMRA) has recommended that a new permanent working group be set up to keep tabs on the use of AI and make sure that regulations can accommodate new developments.
Outsourcing Pharma
AUGUST 19, 2021
The US Food and Drug Administration continues to review potential preventatives and treatments for the virus, and to offer advice to life-sciences professionals and civilians alike.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
AUGUST 20, 2021
Regeneron/Roche's drug found to reduce hospitalisation
Fierce Healthcare
AUGUST 18, 2021
Biden administration to invest $19M to expand telehealth in rural, underserved areas. hlandi. Wed, 08/18/2021 - 08:15.
pharmaphorum
AUGUST 17, 2021
In latest episode of our Health Innovators video interview series, Dr Paul Tunnah speaks to Daphne Zohar, the co-founder and CEO of PureTech Health. They discuss the publicly-listed biotech’s pipeline projects and focus on the BIG (brain-immune-gut) axis as well as PureTech’s interest in digital therapeutics. Daphne explains how she built an impressive team of board advisors for her company, plus the challenges and experience of fund raising.
Outsourcing Pharma
AUGUST 18, 2021
A representative from Clarivate explains how supply chain vulnerabilities can hurt stakeholders, including patientsâand how one solution can close the gap.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Times
AUGUST 20, 2021
Treatment provides therapeutic benefits to adults with the disease
Fierce Healthcare
AUGUST 17, 2021
Maven Clinic nabs $110M funding round and a boost from Oprah to reach unicorn status. hlandi. Tue, 08/17/2021 - 12:50.
pharmaphorum
AUGUST 15, 2021
In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine. They looked at the development of regenerative medicine and where Organicell hopes to add to that field. Then, with the company pivoting to try and help tackle Covid, they also discussed how that change was made possible and where Organicell’s focus will be.
Outsourcing Pharma
AUGUST 18, 2021
The excipients specialist shares findings from its research into the ins and outs of 3D powder bed printed tablets and how it can benefit drug development.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
AUGUST 18, 2021
UK regulator confirms vaccine is “safe and effective” in this age group
Fierce Healthcare
AUGUST 20, 2021
Mayo posts $451M in profit in Q2 amid uneven rebound in patient volumes. rking. Fri, 08/20/2021 - 11:28.
pharmaphorum
AUGUST 19, 2021
A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of the future – no matter what they do or where they are based. The Good Clinical Trials Collaborative (GCTC) has published a draft guidance document, and is asking for the life sciences sector to make its views known. The publication, which is out for public consultation until 15 September, said RCTs played a central role in generating the evidence needed to inform the de
Outsourcing Pharma
AUGUST 19, 2021
The digital pathology firm and image-analysis software developer will partner on artificial intelligence based solutions to improve trial decision making.
Pharma Times
AUGUST 17, 2021
Carrick Therapeutics’ oral CDK7 inhibitor may improve patient outcomes
Fierce Healthcare
AUGUST 19, 2021
Physician pay remained stagnant while productivity slumped in 2020, new survey finds. agliadkovskaya. Thu, 08/19/2021 - 19:00.
pharmaphorum
AUGUST 20, 2021
Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist Exscientia, paying $20 million for the buy-in as part of their $1.2 billion alliance. The unnamed drug candidate acts on an immunological kinase enzyme, which has proven hard to target using conventional drug discovery techniques because challenges relating to “potency, selectivity, and overall drug-like properties,” according to the partners.
Outsourcing Pharma
AUGUST 18, 2021
A leader from the excipients firm discusses how ODTs appeal to seniors and patients on the go, and the formulation-related challenges with such tablets.
The Physician Pharmacist
AUGUST 15, 2021
Applying to medical school is no easy task, but neither is making it through pharmacy school! If you are reading this right now, then you are investigating the same calling I experienced several years ago. Every pharmacy student plays with the fantasy of going to medical school and unfortunately most will never get further than that. I am here to share my insider tips and tricks to optimize your application.
Fierce Healthcare
AUGUST 19, 2021
KFF: Most insurers phasing out cost-sharing waivers for COVID-19 treatments. rking. Thu, 08/19/2021 - 12:10.
pharmaphorum
AUGUST 17, 2021
The Moderna COVID-19 vaccine has become the second jab to be authorised for use in England, Scotland and Wales in children aged 12 to 17 after getting the nod from the Medicines and healthcare products Regulatory Agency (MHRA). It joins the Pfizer/BioNTech vaccine in being an option for that age group, having been approved in Northern Ireland – which remains under the EU regulatory framework – a month ago.
Outsourcing Pharma
AUGUST 19, 2021
The patient matching platform firm will work with Precision for Medicine on solutions to increase diversity, elevate enrollment and speed new therapies.
Pharma Times
AUGUST 20, 2021
Phase III trial showed the drug achieved and maintained target Hb levels
Fierce Healthcare
AUGUST 19, 2021
GoodRx reports spike in drug discount subscribers driving 43% revenue growth in Q2. hlandi. Thu, 08/19/2021 - 12:39.
pharmaphorum
AUGUST 17, 2021
There is plenty of evidence that Novartis’ ophthalmology drug Beovu can match its rivals when it comes to efficacy, with less frequent dosing, but the big question facing the company is whether it is less safe. Data from phase 3 trials of the drug in diabetic macular oedema (DMO) provide some encouragement for Novartis on the safety issue, with Beovu (brolucizumab) found to be roughly equivalent to Bayer and Regeneron’s Eylea (aflibercept) when it came to inflammatory reactions in th
Let's personalize your content